Navigation Links
Inverness Medical Innovations Announces Fourth Quarter 2007 Results
Date:2/20/2008

GAAP Adjustments Basis(a)

Net revenue $157,008 $- $157,008

Cost of sales 89,680 (3,906)(b)(c)(d) 85,774

Gross profit 67,328 3,906 71,234

Gross margin 43% 45%

Operating expenses:

Research and

development 13,917 (1,460)(c)(d) 12,457

Purchase of in-process

research and

development - - -

Selling, general and

administrative 44,584 (2,493)(c)(d) 42,091

Loss on dispositions,

net 307 (307)(e) -

Operating income 8,520 8,166 16,686

Interest and other income

(expense), net (650) 177(c) (473)

Income tax (benefit)

provision 1,843 552(i) 2,395

Net (loss) income $6,027 $7,791 $13,818

Net (loss) income per

common share:

Basic $0.15 $0.36

Diluted $0.15(l) $0.34(l)

Weighted average common

shares - basic 38,885 38,885

Weighted average common

shares - diluted 40,715(l) 40,715(l)

(a) In calculating net income or loss on an adjusted cash basis, the

Company excludes from net income or loss (i) certain non-cash

charges including amortization expense and stock-based compensation

expense, (ii) non-recurring charges and income, and (iii) certain

other charges and income that have a sign
'/>"/>

SOURCE Inverness Medical Innovations
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related biology technology :

1. Inverness Medical Innovations Completes Acquisition of BBI Holdings Plc
2. Correction to Press Release Dated January 31, 2008: Inverness Medical Innovations to Participate at 2008 Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference on February 5, 2008
3. Inverness Medical Innovations to Participate at 2008 Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference on February 5, 2008
4. Inverness Medical Innovations to Participate at JP Morgan Healthcare Conference on January 8, 2008
5. Inverness Medical Innovations Acquires ParadigmHealth
6. Inverness Medical Innovations Agrees to Acquire ParadigmHealth
7. Inverness Medical Innovations Announces Proposed Public Offering of Common Stock
8. Inverness - Chemogen Establish Exclusive License for TB Antibodies
9. Inverness Medical Innovations Agrees to Acquire Panbio Ltd.
10. B-Line Medical and Immersion Medical Announce Partnership
11. MIT researcher addresses biomedical engineering challenges
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... (PRWEB) May 23, 2013 Just released this ... executive coach and author Barbara Roche: “Commit to Confidence: ... , Filled with helpful tips and quotes from the fields ... leaders, and tangible exercises that readers can do on their ... to achieve their personal and professional goals. , ...
(Date:5/22/2013)... Washington, NY (PRWEB) May 22, 2013 ... comprehensive line of accessories for the mobile lifestyle, announces ... charge, sync, protect, and manage multiple iPad devices efficiently. ... award and the 2012 Good Design award, MultiCharger-X is ... the iPad, wherever it is deployed. , ...
(Date:5/22/2013)... , May 22, 2013   Oligomerix, Inc. ... of disease modifying therapeutics for Alzheimer,s disease (AD) ... of its Series B financing, which includes both ... that would represent approximately $2.8M in new investments ... investors supported the raise. Funding ...
(Date:5/22/2013)... NEW ORLEANS , May 22, 2013 /PRNewswire/ ... regenerative medicine, presented new data generated in collaboration with ... leading health economics consultancy) demonstrating the significant healthcare resource ... venous leg ulcers (VLU) place upon the US healthcare ... which reveal annual costs of up to $15 billion ...
Breaking Biology Technology:iLuv Now Shipping the All New MultiCharger-X 2iLuv Now Shipping the All New MultiCharger-X 3Oligomerix, Inc. Completes Series B Financing 2Oligomerix, Inc. Completes Series B Financing 3Organogenesis Presents Findings from Groundbreaking Research Highlighting the Healthcare Resource and Economic Burden of Venous Leg Ulcers and Diabetic Foot Ulcers 2Organogenesis Presents Findings from Groundbreaking Research Highlighting the Healthcare Resource and Economic Burden of Venous Leg Ulcers and Diabetic Foot Ulcers 3Organogenesis Presents Findings from Groundbreaking Research Highlighting the Healthcare Resource and Economic Burden of Venous Leg Ulcers and Diabetic Foot Ulcers 4
... A blend of mobile, electronic learning techniques could be the ... technology for the University of Wisconsin-Madison and director of the ... chapter of the World Future Society last Thursday night ... hardware and culture, Brown talked about where developers are succeeding ...
... dont always have to help people in a significant way ... sale). In reality, people also appreciate little acts of kindness ... paying for meals). , ,While these details may seem trivial ... you and your networking style. Pay attention to how you ...
... earnings may be the least of the news coming ... Milwaukee-based maker of radiology information system (RIS) and picture ... reported record fiscal results this week for the quarter ... of new strategic partnerships and its growing international business. ...
Cached Biology Technology:Technology puts pressure on old education methods 2Little things can be big in networking 2Little things can be big in networking 3Balance-sheet success leads to hunt for market dominance at Merge 2Balance-sheet success leads to hunt for market dominance at Merge 3
(Date:5/21/2013)... in the body, stem cells in the blood ... into mature immune cells that can fight off ... these cell populations, potentially leading to the development ... a team of researchers led by biologists at ... that, in mouse models, the molecule microRNA-146a (miR-146a) ...
(Date:5/21/2013)... Center today awarded 12 research grants, totaling nearly ... efforts. , The two-year grants of up to ... track the remediation of harmful algae blooms; assess ... plant invasions; study chromosomal damage in tree swallow ... , The grants were awarded to multidisciplinary teams ...
(Date:5/21/2013)... The American Chemical Society (ACS), the world,s largest ... 246th National Meeting & Exposition, September 8-12, 2013, ... the Indiana Convention Center and at area hotels. ... discoveries that span science,s horizons from astronomy ... broadcast and online journalists a rich assortment of ...
Breaking Biology News(10 mins):Keeping stem cells strong 2U-M Water Center awards $570K in Great Lakes restoration grants 2U-M Water Center awards $570K in Great Lakes restoration grants 3U-M Water Center awards $570K in Great Lakes restoration grants 4
... A comprehensive system of vaccine development in the U.S. ... 99 percent in illness from ten vaccine-preventable diseases during ... taken for granted, however, as the vaccine system now ... a review article in the May/June issue of Health ...
... diseases (STDs) requires treatment of the sexual partners of ... men with antibiotics to give their partners is more ... partners, according to an article in the Sept. 1 ... with chlamydia or gonorrhea were more likely to see ...
... a cancer drug that can burrow into a tumor, ... anti-cancer toxins, all while leaving healthy cells unscathed. , ... that. , The dual-chamber, double-acting, drug-packing "nanocell" proved effective ... of cancers--melanoma and Lewis lung cancer--in mice. , The ...
Cached Biology News:Fragile US vaccine system needs improvement despite dramatic gains in health over past century 2Fragile US vaccine system needs improvement despite dramatic gains in health over past century 3New study: Sexually transmitted disease treatment can be effectively administered by sex partners 2New study: Sexually transmitted disease treatment can be effectively administered by sex partners 3MIT engineers an anti-cancer smart bomb 2
... Resolution - Efficiently separates ... to 1000 bp. It ... PCR fragments, small DNA ... enzyme digestion, and double-stranded ...
... Anti-PRK2 MW 140kDa ... Immunogen Peptide spanning amino acids ... Purification immunoaffinity purified Quality ... RIPA lysates from HeLa cells. ...
MarrowMAX Bone Marrow Medium...
Histone H2A Polyclonal Antibody 100 ug affinity purified rabbit polyclonal antibody. Detects ~14 kDa Histone H2A. It does not cross-react with other Histones. Reacts with human/mouse/rat. Performs w...
Biology Products: